Baxter International Inc. (BAX.VI)
| Previous close | 31.24 |
| Open | 30.69 |
| Bid | 30.24 x 0 |
| Ask | 30.54 x 0 |
| Day's range | 30.39 - 31.17 |
| 52-week range | 30.05 - 44.35 |
| Volume | |
| Avg. volume | 9 |
| Market cap | 16.456B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.08 (3.56%) |
| Ex-dividend date | 31 May 2024 |
| 1y target est | N/A |
- Business Wire
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
DEERFIELD, Ill., June 06, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.
- Business Wire
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
- Business Wire
Baxter to Present at Jefferies 2024 Global Healthcare Conference
DEERFIELD, Ill., May 23, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024.
